top of page

16th Annual Drug Discovery
Innovation Forum 2025

10th & 11th September 2025
Hyatt Regency Barcelona Tower, Spain

Co-located with The 8th Annual Cell & Gene Therapy Innovation Summit

The 16th Annual Drug Discovery Innovation Forum #DDIF

10th & 11th September 2025
The Hyatt Regency Barcelona Tower, Spain

Co-located

16th Annual Drug Discovery Innovation Forum 2025

10th & 11th September 2025

Co-located with The 8th Annual Cell & Gene Therapy Innovation Forum #CGTI

DDIF ATTENDEES

Bayer is an attendee of The Annual Drug Discovery Innovation Forum DDIF 2024

TU Berlin is an attendee of The Annual Drug Discovery Innovation Forum DDIF 2024

Ferring Pharmaceuticals is an attendee of The Annual Drug Discovery Innovation Forum DDIF 2024

AstraZeneca is an attendee of The Annual Drug Discovery Innovation Forum DDIF 2024

Pistoia Alliance is an attendee of The Annual Drug Discovery Innovation Forum DDIF 2024

LEO Pharma is an attendee of The Annual Drug Discovery Innovation Forum DDIF 2024

Astellas is an attendee of The Annual Drug Discovery Innovation Forum DDIF 2024

Leiden Universiteit is an attendee of The Annual Drug Discovery Innovation Forum DDIF 2024

Parkinsons UK is an attendee of The Annual Drug Discovery Innovation Forum DDIF 2024

Abbvie is an attendee of The Annual Drug Discovery Innovation Forum DDIF

Insilico Medicine is an attendee of The 15th Annual Drug Discovery Innovation Forum #DDIF which is being hosted in The Hotel Palace Berlin on the 4th & 5th September 2024

LEADERS SHAPING THE FUTURE

KEYNOTES & ADVISORY

“Our very survival depends on our ability to stay awake, to adjust to new ideas, to remain vigilant and to face the challenge of change.” – Martin Luther King

Uwe Gottschalk, Operating Partner at Keensight Capital who was previously the CSO of Lonza is speaking at The Annual Drug Discovery Innovation Forum #DDIF 2024

For the patients, we must do better.

10th & 11th September 2025

Hyatt Regency Barcelona Tower, Spain

DDIF was formed 15 years ago and our mission remains the same - to push boundaries to affect change, for patients.

To continue this statement - drug discovery and development must evolve and innovate towards new modes of action. Embrace next-generation technology such as ML, AR, Generative AI, LLM and so forth. There is no avoiding it. To truly reduce drug discovery time and accelerate clinical trial development, we must advance towards digital transformation and break down silos and barriers we often create ourselves.

DDIF Speaker, speaking at The Annual Drug Discovery Innovation Forum #DDIF

ddif speaker, speaking at The Annual Drug Discovery Innovation Forum #DDIF

Learn more

Confirmed Speakers

Learn more

Register Interest

Catarina Leitao, MSAT Senior Engineer at 4TE - a ValGenesis Company speaking at The 16th Annual Bio Innovation Leaders Summit #BILS

Learn more

Programme

Laura Matz

Chief Science & Technology Officer at Merck Group

Jose Duca

Global Head of Computer-Aided Drug Discovery at Novartis

Nuno Prego Ramos

Founder & CEO of Valvian

Petrina Kamya

VP & Global Head of AI Platforms at Insilico Medicine

Werngard Czechtizky

Executive Director Head Medicinal Chemistry, Respiratory and Immunology at AstraZeneca

Rudi Schmidt

Chief Operating Officer at Institute for Healthier Living Abu Dhabi

Louis Boon

CSO of JJP Biologics

Uli Schmidt

Executive Director, Structural Chemistry at Gilead Sciences

CONFIRMED SPEAKERS 2025

The Journey Continues

PREVIOUS SPEAKERS

Laura Matz, Chief Science & Technology Officer at Merck KGaA, Darmstadt, Germanyis a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Nuno Prego Ramos, Founder & CEO of Valvian is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Petrina Kamya, Global Head of AI Platforms, VP Insilico Medicine is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Ashwini Ghogare, Head of AI and Automation for Drug Discovery at Merck KGaA is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Tim Hoctor, Advisor and Consultant to the Pistoia Alliance is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Jose Duca, Global Head of Computer-Aided Drug Discovery at Novartis is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Mati Gill, CEO of Aion Labs is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Richard Bickerton, Chief Systems Scientist at Exscientia is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Christian Olsen, AVP, Industry Principal, Biologics at Dotmatics is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Jonathan Mason, Senior Research Advisors to Global Biotechs is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Rudi Schmidt, Chief Operating Officer at Institute for Healthier Living Abu Dhabi is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Fred Manby, Co-Founder & CTO of Iambic Therapeutics is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Andreas Busch, Chief Innovation Officer at Absci is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Sheila Elz, Master Data Manager at Bayer is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Vivek K Vishnudas, VP, Drug Discovery Non-Clinical Dev, CTO and R&D Site Head at BPGbio is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Louis Boon, CSO of JJP Biologics is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Uli Schmitz, Executive Director, Structural Chemistry at Gilead Sciences

Bertram Weiss, Independent Scientific Advisor of Bertram Weiss Consulting - Previously VP, Head of Research Product Platforms at Bayer is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Martin Hofmann-Apitius, Head of the Department of Bioinformatics at Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.

Amaury Fernández-Montalván, Lead Innovation at Boehringer Ingelheim is a previous speaker of The Annual Drug Discovery Innovation Forum #DDIF which is an exclusive summit which brings together the pioneers shaping the future of the drug discovery landscape.